133 related articles for article (PubMed ID: 38235869)
1. Prognostic role of the systemic immune-inflammation index and pan-immune inflammation value for outcomes of breast cancer: a systematic review and meta-analysis.
Cheng HW; Wang T; Yu GC; Xie LY; Shi B
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):180-190. PubMed ID: 38235869
[TBL] [Abstract][Full Text] [Related]
2. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
Ji Y; Wang H
World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
Zhang Y; Sun Y; Zhang Q
Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
5. The role of preoperative systemic immune-inflammation index in predicting the prognosis of patients with digestive tract cancers: A meta-analysis.
Gao H; Wusiman L; Cao BW; Wujieke A; Zhang WB
Transpl Immunol; 2022 Aug; 73():101613. PubMed ID: 35500845
[TBL] [Abstract][Full Text] [Related]
6. Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer.
Kayar R; Bastug Y; Tokuc E; Topaktas R; Akyurek EA; Kayar K; Artuk I; Ozturk M
Int Urol Nephrol; 2024 Feb; 56(2):509-518. PubMed ID: 37773579
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.
Meng L; Yang Y; Hu X; Zhang R; Li X
J Transl Med; 2023 Feb; 21(1):79. PubMed ID: 36739407
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis.
Li M; Li Z; Wang Z; Yue C; Hu W; Lu H
Clin Exp Med; 2022 Nov; 22(4):637-646. PubMed ID: 35022918
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pan-immune-inflammation value in colorectal cancer patients: A systematic review and meta-analysis.
Yang XC; Liu H; Liu DC; Tong C; Liang XW; Chen RH
Front Oncol; 2022; 12():1036890. PubMed ID: 36620576
[TBL] [Abstract][Full Text] [Related]
10. High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis.
Liu W; Zhang Y; Wang M; Wang M; Yang Q
Front Oncol; 2023; 13():1229349. PubMed ID: 38023187
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis.
Zeng Z; Xu S; Wang D; Qin G
Syst Rev; 2022 Nov; 11(1):247. PubMed ID: 36403072
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.
Mao H; Yang F
Front Oncol; 2023; 13():1193962. PubMed ID: 37342198
[TBL] [Abstract][Full Text] [Related]
14. The Change of Systemic Immune-Inflammation Index Independently Predicts Survival of Colorectal Cancer Patients after Curative Resection.
Chen Q; Wu H; Guo X; Gu K; Wang W; Chen X; Ji S; Yang H; Zhu J
Mediators Inflamm; 2020; 2020():4105809. PubMed ID: 33293896
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis.
Wang Y; Li Y; Chen P; Xu W; Wu Y; Che G
Ann Transl Med; 2019 Sep; 7(18):433. PubMed ID: 31700869
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Colorectal Cancer.
Li J; Shao J; Zhang X; Chen X; Zhao W; Qian H; Cui X; Jiang X
Gastroenterol Res Pract; 2020; 2020():8781674. PubMed ID: 33293949
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of the pan-immune-inflammation value in breast cancer patients.
Qi X; Qiao B; Song T; Huang D; Zhang H; Liu Y; Jin Q; Yang M; Liu D
Front Oncol; 2023; 13():1223786. PubMed ID: 37711203
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis.
Qiu Y; Zhang Z; Chen Y
Front Oncol; 2021; 11():537140. PubMed ID: 33777726
[TBL] [Abstract][Full Text] [Related]
19. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis.
Li X; Gu L; Chen Y; Chong Y; Wang X; Guo P; He D
Ann Med; 2021 Dec; 53(1):1827-1838. PubMed ID: 34647517
[TBL] [Abstract][Full Text] [Related]
20. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.
Guven DC; Erul E; Yilmaz F; Yasar S; Yildirim HC; Ercan F; Kaygusuz Y; Cayiroz K; Ucdal MT; Yesil F; Yazici G; Cengiz M; Gullu I; Aksoy S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2471-2478. PubMed ID: 36565325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
